ITCI
Lord, Abbett & Co’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-516,719
| Closed | -$43.2M | – | 589 |
|
|
2024
Q4 | $43.2M | Sell |
516,719
-112,120
| -18% | -$9.36M | 0.14% | 196 |
|
|
2024
Q3 | $46M | Sell |
628,839
-4,619
| -0.7% | -$338K | 0.15% | 188 |
|
|
2024
Q2 | $43.4M | Buy |
633,458
+160,771
| +34% | +$11M | 0.14% | 188 |
|
|
2024
Q1 | $32.7M | Sell |
472,687
-300,280
| -39% | -$20.8M | 0.11% | 247 |
|
|
2023
Q4 | $55.4M | Buy |
772,967
+120,937
| +19% | +$8.66M | 0.19% | 149 |
|
|
2023
Q3 | $34M | Sell |
652,030
-640,738
| -50% | -$33.4M | 0.13% | 230 |
|
|
2023
Q2 | $81.9M | Buy |
1,292,768
+588,837
| +84% | +$37.3M | 0.28% | 106 |
|
|
2023
Q1 | $38.1M | Sell |
703,931
-183,442
| -21% | -$9.93M | 0.14% | 227 |
|
|
2022
Q4 | $47M | Sell |
887,373
-1,131,313
| -56% | -$59.9M | 0.17% | 175 |
|
|
2022
Q3 | $93.9M | Buy |
2,018,686
+167,737
| +9% | +$7.8M | 0.34% | 78 |
|
|
2022
Q2 | $106M | Sell |
1,850,949
-130,407
| -7% | -$7.44M | 0.37% | 62 |
|
|
2022
Q1 | $121M | Sell |
1,981,356
-149,464
| -7% | -$9.15M | 0.32% | 87 |
|
|
2021
Q4 | $112M | Buy |
2,130,820
+42,786
| +2% | +$2.24M | 0.25% | 121 |
|
|
2021
Q3 | $77.8M | Sell |
2,088,034
-57,554
| -3% | -$2.15M | 0.19% | 168 |
|
|
2021
Q2 | $87.6M | Buy |
2,145,588
+23,448
| +1% | +$957K | 0.21% | 143 |
|
|
2021
Q1 | $72M | Buy |
+2,122,140
| New | +$72M | 0.18% | 181 |
|
|
2016
Q3 | – | Sell |
-64,816
| Closed | -$2.52M | – | 946 |
|
|
2016
Q2 | $2.52M | Sell |
64,816
-86,448
| -57% | -$3.36M | 0.01% | 815 |
|
|
2016
Q1 | $4.21M | Sell |
151,264
-34,769
| -19% | -$967K | 0.01% | 743 |
|
|
2015
Q4 | $10M | Buy |
186,033
+49,914
| +37% | +$2.68M | 0.03% | 598 |
|
|
2015
Q3 | $5.45M | Buy |
+136,119
| New | +$5.45M | 0.02% | 718 |
|